Finance

Lists
SNDX:NASDAQ
Syndax Pharmaceuticals Inc
16,99 $
+0,53%
(+0,090) 1D
17,75 $
+4,47% (+0,76)
After hours
Closed: 9 қаз., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SNDX...
Open
16,91 $
High
17,42 $
Low
16,78 $
Mkt. cap
1,52 млрд
Avg. vol.
1,73 млн
Volume
1,46 млн
52-wk high
25,59 $
52-wk low
13,00 $
EPS
-2,52 $
Beta
0,43
Shares outstanding
89,30 млн
No. of employees
298
Open
16,91 $
High
17,42 $
Low
16,78 $
Mkt. cap
1,52 млрд
Avg. vol.
1,73 млн
Volume
1,46 млн
52-wk high
25,59 $
52-wk low
13,00 $
EPS
-2,52 $
Beta
0,43
Shares outstanding
89,30 млн
No. of employees
298
News stories
From web sources and news partners
About Syndax Pharmaceuticals Inc
CEO-
Employees298
Founded2005
Headquarters-
Sector-
Websitesyndax.com
Analyst ratings
Based on 10 analysts giving stock ratings to SNDX in the past 3 months
Strong buy
Buy
10
Hold
0
Sell
0
12-month forecast
Based on 10 Wall Street analysts offering 12 month price targets for SNDX in the last 3 months.
Highest
Current 16,99 $
57,00 $ (+235,49%)
Average
37,33 $ (+119,72%)
Lowest
26,00 $ (+53,03%)
Analyst
Recommendation
Action
Price target
Projected
Date
Andres Y. Maldonado
H.C. Wainwright
Buy
Reiterated
38,00 $
+123,7%
10/01/2026
Yigal Nochomovitz
Citi
Buy
Maintained
57,00 $
+235,5%
09/29/2026
David Dai
UBS
Buy
Reiterated
33,00 $
+94,2%
08/21/2026
Stephen Willey
Stifel Nicolaus
Buy
Maintained
40,00 $
+135,4%
08/14/2026
Anupam Rama
J.P. Morgan
Buy
Maintained
40,00 $
+135,4%
08/11/2026
Jason Zemansky
Bank of America Securities
Buy
Maintained
26,00 $
+53%
08/05/2026
Etzer Darout
Barclays
Buy
Maintained
37,00 $
+117,8%
08/05/2026
Phil Nadeau
TD Cowen
Buy
Maintained
-
-
08/04/2026
Bradley Canino
Guggenheim
Buy
Maintained
31,00 $
+82,5%
07/14/2026
Corinne Johnson
Goldman Sachs
Buy
Maintained
34,00 $
+100,1%
07/14/2026
Faisal Khurshid
Jefferies
Buy
Maintained
37,00 $
+117,8%
05/01/2026
Unknown Analyst
Jefferies
Buy
Maintained
40,00 $
+135,4%
03/30/2026
Unknown Analyst
Mizuho Securities
Buy
Maintained
43,00 $
+153,1%
03/30/2026
Salim Syed
Mizuho Securities
Buy
Maintained
43,00 $
+153,1%
03/30/2026
Last report
2026 ж. 04 там.
Fiscal period
Q2 2026
-0,55 $ / -0,44 $
-26,01%miss
Revenue / Est. (USD)
72,79 млн / 79,56 млн
-8,51%miss
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
45,87 млн
68,73 млн
64,86 млн
72,79 млн
Cost of goods sold
58,38 млн
81,35 млн
61,48 млн
71,24 млн
Cost of revenue
58,38 млн
81,35 млн
61,48 млн
71,24 млн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
44,92 млн
49,93 млн
37,59 млн
41,54 млн
Operating expense
44,92 млн
49,93 млн
37,59 млн
41,54 млн
Total operating expenses
103,30 млн
131,28 млн
99,07 млн
112,78 млн
Operating income
-57,43 млн
-62,55 млн
-34,20 млн
-40,00 млн
Other non operating income
-275,00 м.
-201,00 м.
-186,00 м.
-438,00 м.
EBT including unusual items
-60,72 млн
-68,01 млн
-42,67 млн
-49,36 млн
EBT excluding unusual items
-60,72 млн
-68,01 млн
-42,67 млн
-49,36 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-60,72 млн
-68,01 млн
-42,67 млн
-49,36 млн
Net profit margin
-132,36%
-98,96%
-65,79%
-67,82%
Earnings per share
-0,70
-0,78
-0,48
-0,55
Interest and investment income
5,27 млн
4,33 млн
3,56 млн
3,75 млн
Interest expense
-8,28 млн
-9,59 млн
-11,85 млн
-12,68 млн
Net interest expenses
-3,01 млн
-5,26 млн
-8,28 млн
-8,93 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
-57,42 млн
-62,54 млн
-34,20 млн
-39,99 млн
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google қолданбалары